Update on Myocarditis and Inflammatory Cardiomyopathy: Reemergence of Endomyocardial Biopsy;Actualización sobre miocarditis y miocardiopatía inflamatoria: el resurgir de la biopsia endomiocárdica

Revista Espanola de Cardiologia

Volumn 69, Issue 2, 2016, Pages 178-187

  Dominguez, Fernando ^a,b   Kühl, Uwe ^b   Pieske, Burkert ^b,c   Garcia Pavia, Pablo ^a   Tschöpe, Carsten ^b,d  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^d DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

Endomyocardial biopsy; Inflammatory cardiomyopathy; Myocarditis

Indexed keywords

ANTIVIRUS AGENT; BIOLOGICAL MARKER;

ARTICLE; AUTOIMMUNE DISEASE; CARDIOMYOPATHY; CARDIOVASCULAR MAGNETIC RESONANCE; HEART MUSCLE BIOPSY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; MYOCARDITIS; VIRUS GENOME; BIOPSY; CARDIAC IMAGING; CARDIOMYOPATHIES; ELECTROCARDIOGRAPHY; ENDOCARDIUM; FLUOROSCOPY; IMAGE GUIDED BIOPSY; METABOLISM; PATHOLOGY; PROCEDURES;

BIOMARKERS; BIOPSY; CARDIAC IMAGING TECHNIQUES; CARDIOMYOPATHIES; ELECTROCARDIOGRAPHY; ENDOCARDIUM; FLUOROSCOPY; HUMANS; IMAGE-GUIDED BIOPSY; MYOCARDITIS;

EID: 84958832245     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2015.10.018     Document Type: Short Survey

References (57)

1. A.L. Caforio, S. Pankuweit, E. Arbustini, C. Basso, J. Gimeno-Blanes, S.B. Felix, and et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases Eur Heart J. 34 2013 2636 2648
2. A.L. Caforio, F. Calabrese, A. Angelini, F. Tona, A. Vinci, S. Bottaro, and et al. A prospective study of biopsy-proven myocarditis: Prognostic relevance of clinical and aetiopathogenetic features at diagnosis Eur Heart J. 28 2007 1326 1333
3. H.P. Schultheiss, U. Kuhl, and L.T. Cooper The management of myocarditis Eur Heart J. 32 2011 2616 2625
4. H.T. Aretz Myocarditis: The Dallas criteria Hum Pathol. 18 1987 619 624
5. U. Kuhl, M. Pauschinger, M. Noutsias, B. Seeberg, T. Bock, D. Lassner, and et al. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction Circulation. 111 2005 887 893
6. J.P. Breinholt, M. Moulik, W.J. Dreyer, S.W. Denfield, J.J. Kim, J.L. Jefferies, and et al. Viral epidemiologic shift in inflammatory heart disease: The increasing involvement of parvovirus B19 in the myocardium of pediatric cardiac transplant patients J Heart Lung Transplant. 29 2010 739 746
7. P. Norja, K. Hokynar, L.M. Aaltonen, R. Chen, A. Ranki, E.K. Partio, and et al. Bioportfolio: Lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue Proc Natl Acad Sci U S A. 103 2006 7450 7453
8. U. Kuhl, and H.P. Schultheiss Myocarditis: Early biopsy allows for tailored regenerative treatment Dtsch Arztebl Int. 109 2012 361 368
9. C. Schmidt-Lucke, F. Escher, S. Van Linthout, U. Kuhl, K. Miteva, J. Ringe, and et al. Cardiac migration of endogenous mesenchymal stromal cells in patients with inflammatory cardiomyopathy Mediators Inflamm. 2015 2015 308185
10. U. Kuhl, D. Lassner, A. Dorner, M. Rohde, F. Escher, B. Seeberg, and et al. A distinct subgroup of cardiomyopathy patients characterized by transcriptionally active cardiotropic erythrovirus and altered cardiac gene expression Basic Res Cardiol. 108 2013 372
11. L.T. Cooper Jr. Myocarditis N Engl J Med 360 2009 1526 1538
12. C. Ukena, F. Mahfoud, I. Kindermann, R. Kandolf, M. Kindermann, and M. Bohm Prognostic electrocardiographic parameters in patients with suspected myocarditis Eur J Heart Fail. 13 2011 398 405
13. G.M. Felker, J.P. Boehmer, R.H. Hruban, G.M. Hutchins, E.K. Kasper, K.L. Baughman, and et al. Echocardiographic findings in fulminant and acute myocarditis J Am Coll Cardiol. 36 2000 227 232
14. J.F. Guadalajara-Boo, M.E. Ruiz-Esparza, A. Aranda Frausto, M.V. Soto Abraham, and J. Gaspar-Hernández Imagen histológica y angiocardiográfica de miocarditis aguda por dengue Rev Esp Cardiol. 67 2014 226 227
15. M. Kasner, D. Sinning, F. Escher, D. Lassner, U. Kuhl, H.P. Schultheiss, and et al. The utility of speckle tracking imaging in the diagnostic of acute myocarditis, as proven by endomyocardial biopsy Int J Cardiol. 168 2013 3023 3024
16. M.G. Friedrich, U. Sechtem, J. Schulz-Menger, G. Holmvang, P. Alakija, L.T. Cooper, et al. International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis Cardiovascular magnetic resonance in myocarditis: A JACC White Paper J Am Coll Cardiol. 53 2009 1475 1487
17. H. Abdel-Aty, P. Boye, A. Zagrosek, R. Wassmuth, A. Kumar, D. Messroghli, and et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: Comparison of different approaches J Am Coll Cardiol. 45 2005 1815 1822
18. A.H. Aletras, P. Kellman, J.A. Derbyshire, and A.E. Arai ACUT2E TSE-SSFP: A hybrid method for T2-weighted imaging of edema in the heart Magn Reson Med. 59 2008 229 235
19. H. Mahrholdt, C. Goedecke, A. Wagner, G. Meinhardt, A. Athanasiadis, H. Vogelsberg, and et al. Cardiovascular magnetic resonance assessment of human myocarditis: A comparison to histology and molecular pathology Circulation. 109 2004 1250 1258
20. C. Ukena, M. Kindermann, F. Mahfoud, J. Geisel, P.M. Lepper, R. Kandolf, and et al. Diagnostic and prognostic validity of different biomarkers in patients with suspected myocarditis Clin Res Cardiol. 103 2014 743 751
21. J. Jensen, L.P. Ma, M.L. Fu, D. Svaninger, P.A. Lundberg, and O. Hammarsten Inflammation increases NT-proBNP and the NT-proBNP/BNP ratio Clin Res Cardiol. 99 2010 445 452
22. U. Kuhl, and H.P. Schultheiss Viral myocarditis Swiss Med Wkly. 144 2014 w14010
23. L.T. Cooper, K.L. Baughman, A.M. Feldman, A. Frustaci, M. Jessup, U. Kuhl, and et al. The role of endomyocardial biopsy in the management of cardiovascular disease: A scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology Eur Heart J. 28 2007 3076 3093
24. M. Holzmann, A. Nicko, U. Kuhl, M. Noutsias, W. Poller, W. Hoffmann, and et al. Complication rate of right ventricular endomyocardial biopsy via the femoral approach: A retrospective and prospective study analyzing 3048 diagnostic procedures over an 11-year period Circulation. 118 2008 1722 1728
25. J.W. Deckers, J.M. Hare, and K.L. Baughman Complications of transvenous right ventricular endomyocardial biopsy in adult patients with cardiomyopathy: A seven-year survey of 546 consecutive diagnostic procedures in a tertiary referral center J Am Coll Cardiol. 19 1992 43 47
26. C. Chimenti, and A. Frustaci Contribution and risks of left ventricular endomyocardial biopsy in patients with cardiomyopathies: A retrospective study over a 28-year period Circulation. 128 2013 1531 1541
27. C. Tschope, B. Kherad, and H.P. Schultheiss How to perform an endomyocardial biopsy? Turk Kardiyol Dern Ars. 43 2015 572 575
28. E. Schulz, A. Jabs, T. Gori, U. Hink, E. Sotiriou, C. Tschope, and et al. Feasibility and safety of left ventricular endomyocardial biopsy via transradial access: Technique and initial experience Catheter Cardiovasc Interv. 86 2015 761 765
29. F. Escher, D. Lassner, U. Kuhl, U. Gross, D. Westermann, W. Poller, and et al. Analysis of endomyocardial biopsies in suspected myocarditis - diagnostic value of left versus right ventricular biopsy Int J Cardiol. 177 2014 76 78
30. P. Richardson, W. McKenna, M. Bristow, B. Maisch, B. Mautner, J. O'Connell, and et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies Circulation. 93 1996 841 842
31. F. Escher, U. Kuhl, D. Lassner, A. Stroux, D. Westermann, C. Skurk, and et al. Presence of perforin in endomyocardial biopsies of patients with inflammatory cardiomyopathy predicts poor outcome Eur J Heart Fail. 16 2014 1066 1072
32. R.E. McCarthy, J.P. Boehmer, R.H. Hruban, G.M. Hutchins, E.K. Kasper, J.M. Hare, and et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis N Engl J Med. 342 2000 690 695
33. L.T. Cooper Jr., G.J. Berry, and R. Shabetai Idiopathic giant-cell myocarditis - natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators N Engl J Med. 336 1997 1860 1866
34. L.T. Cooper Jr., J.M. Hare, H.D. Tazelaar, W.D. Edwards, R.C. Starling, M.C. Deng, et al. Giant Cell Myocarditis Treatment Trial Investigators Usefulness of immunosuppression for giant cell myocarditis Am J Cardiol. 102 2008 1535 1539
35. I. Kindermann, M. Kindermann, R. Kandolf, K. Klingel, B. Bultmann, T. Muller, and et al. Predictors of outcome in patients with suspected myocarditis Circulation. 118 2008 639 648
36. M. Pauschinger, N.E. Bowles, F.J. Fuentes-Garcia, V. Pham, U. Kuhl, P.L. Schwimmbeck, and et al. Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction Circulation. 99 1999 1348 1354
37. H.J. Why, B.T. Meany, P.J. Richardson, E.G. Olsen, N.E. Bowles, L. Cunningham, and et al. Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy Circulation. 89 1994 2582 2589
38. U. Kuhl, D. Lassner, J. Von Schlippenbach, W. Poller, and H.P. Schultheiss Interferon-beta improves survival in enterovirus-associated cardiomyopathy J Am Coll Cardiol. 60 2012 1295 1296
39. B.D. Bultmann, K. Klingel, K. Sotlar, C.T. Bock, H.A. Baba, M. Sauter, and et al. Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: An endothelial cell-mediated disease Hum Pathol. 34 2003 92 95
40. U. Kuhl, M. Rohde, D. Lassner, U.M. Gross, F. Escher, and H.P. Schultheiss miRNA as activity markers in Parvo B19 associated heart disease Herz. 37 2012 637 643
41. C. Tschope, C.T. Bock, M. Kasner, M. Noutsias, D. Westermann, P.L. Schwimmbeck, and et al. High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction Circulation. 111 2005 879 886
42. P.E. Pellett, D.V. Ablashi, P.F. Ambros, H. Agut, M.T. Caserta, V. Descamps, and et al. Chromosomally integrated human herpesvirus 6: Questions and answers Rev Med Virol. 22 2012 144 155
43. F. Escher, U. Kuhl, U. Gross, D. Westermann, W. Poller, C. Tschope, and et al. Aggravation of left ventricular dysfunction in patients with biopsy-proven cardiac human herpesvirus A and B infection J Clin Virol. 63 2015 1 5
44. A.J. Camm, G.Y. Lip, R. De Caterina, I. Savelieva, D. Atar, S.H. Hohnloser, and et al. 2012 focused update of the ESC guidelines for the management of atrial fibrillation: An update of the 2010 ESC guidelines for the management of atrial fibrillation - developed with the special contribution of the European Heart Rhythm Association Europace. 14 2012 1385 1413
45. A. Frustaci, M.A. Russo, and C. Chimenti Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: The TIMIC study Eur Heart J. 30 2009 1995 2002
46. M. Anguita-Sánchez, J.C. Castillo-Domínguez, D. Mesa-Rubio, M. Ruiz-Ortiz, A. López-Granados, and J. Suárez de Lezo ¿Se deben mantener los inhibidores de la enzima de conversión de la angiotensina a largo plazo en pacientes que normalizan la fracción de eyección tras un episodio de miocarditis aguda? Rev Esp Cardiol. 59 2006 1199 1201
47. A. Frustaci, C. Chimenti, F. Calabrese, M. Pieroni, G. Thiene, and A. Maseri Immunosuppressive therapy for active lymphocytic myocarditis: Virological and immunologic profile of responders versus nonresponders Circulation. 107 2003 857 863
48. B. Maisch, and S. Pankuweit Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy Herz. 37 2012 644 656
49. G. Metzgeroth, C. Walz, P. Erben, H. Popp, A. Schmitt-Graeff, C. Haferlach, and et al. Safety and efficacy of imatinib in chronic eosinophilic leukaemia and hypereosinophilic syndrome: A phase-II study Br J Haematol. 143 2008 707 715
50. A.L. Caforio, J.H. Goldman, A.J. Haven, K.M. Baig, L.D. Libera, and W.J. McKenna Circulating cardiac-specific autoantibodies as markers of autoimmunity in clinical and biopsy-proven myocarditis. The Myocarditis Treatment Trial Investigators Eur Heart J. 18 1997 270 275
51. M. Dandel, G. Wallukat, A. Englert, H.B. Lehmkuhl, C. Knosalla, and R. Hetzer Long-term benefits of immunoadsorption in beta(1)-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy Eur J Heart Fail. 14 2012 1374 1388
52. U. Kuhl, M. Pauschinger, P.L. Schwimmbeck, B. Seeberg, C. Lober, M. Noutsias, and et al. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction Circulation. 107 2003 2793 2798
53. C.T. Bock, K. Klingel, and R. Kandolf Human parvovirus B19-associated myocarditis N Engl J Med. 362 2010 1248 1249
54. C. Schmidt-Lucke, F. Spillmann, T. Bock, U. Kuhl, S. Van Linthout, H.P. Schultheiss, and et al. Interferon beta modulates endothelial damage in patients with cardiac persistence of human parvovirus B19 infection J Infect Dis. 201 2010 936 945
55. U. Kuhl, D. Lassner, N. Wallaschek, U.M. Gross, G.R. Krueger, B. Seeberg, and et al. Chromosomally integrated human herpesvirus 6 in heart failure: Prevalence and treatment Eur J Heart Fail. 17 2015 9 19
56. J.S. Orange, E.M. Hossny, C.R. Weiler, M. Ballow, M. Berger, F.A. Bonilla, and et al. Use of intravenous immunoglobulin in human disease: A review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology J Allergy Clin Immunol. 117 2006 S525 S553
57. D.M. McNamara, R. Holubkov, R.C. Starling, G.W. Dec, E. Loh, G. Torre-Amione, and et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy Circulation. 103 2001 2254 2259